NCT06622239View on ClinicalTrials.gov

Trial to Evaluate the Effects of Naltrexone in Nonsuicidal Self-injury

PHASE2Not yet recruitingINTERVENTIONAL
Enrollment

150

Participants

Timeline

Start Date

December 1, 2024

Primary Completion Date

February 28, 2027

Study Completion Date

May 31, 2027

Conditions
Nonsuicidal Self-Injury
Interventions
DRUG

Naltrexone

naltrexone 50mg for 6 weeks

DRUG

Placebo

placebo for 6 weeks

Trial Locations (1)

03080

Seoul National University Hospital, Seoul

All Listed Sponsors
collaborator

Whanin Pharmaceutical Company

INDUSTRY

lead

Seoul National University Hospital

OTHER